RxDoctor Payments DataLook up a doctor →

Alan Zajarias, MD

Interventional Cardiology · Saint Louis, MONPI 1679696579

Payments from drug & device makers

$1,624,013in general payments, 2019–2025

Across 740 payments — averaging $2194.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1.2M
  • Medtronic$247K
  • Siemens Medical Solutions USA, Inc.$127K
  • Boston Scientific$24K
  • Abiomed$19K
  • Admedus Corporation$14K
  • plus $24K from 17 others

What the payments were for

  • Consulting fees$55,80927%
  • Speaking & faculty fees$82,05640%
  • Travel & lodging$44,75022%
  • Food & beverage$20,34910%
  • Education$210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,624,013 in reported general payments places this provider in the 95th percentile of 182 interventional cardiology providers in Missouri.

See all interventional cardiology providers in Missouri

Medicare billing

Part B allowed, 2024
$187,031
Medicare patients
418
Services billed
1,036

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban203$159,532
EntrestoSacubitril/Valsartan107$82,265
JardianceEmpagliflozin78$72,727
FarxigaDapagliflozin Propanediol78$71,123
XareltoRivaroxaban16$20,776
Praluent PenAlirocumab17$13,842
VascepaIcosapent Ethyl18$10,729
Repatha SureclickEvolocumab11$6,074
Metoprolol Succinate305$3,860
Ranolazine ErRanolazine19$2,371
Atorvastatin Calcium214$2,354
Rosuvastatin Calcium176$1,849
Potassium Chloride96$1,611
Carvedilol192$1,377
Ezetimibe54$1,270

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →